Machine learning model predicts radiotherapy response in nasopharyngeal carcinoma patients using gene expression data.

Key Points Revenue (GAAP) exceeded analyst estimates by 10.2% for Q2 2025, with GAAP net revenue rising to $10.3 million, driven by growth in LOQTORZI sales. Non-GAAP EPS missed expectations at $(0.34 ...

LOQTORZI net revenue was $10.0 million, a 36% increase over Q1 2025 -- Data readouts for CHS-114 and casdozokitug on track for 1H 2026 -- Q2 2025 ending cash, cash equivalents and marketable ...

A research team from Southern Medical University has developed a machine learning-based gene model that predicts whether ...

Nasopharyngeal carcinoma (NPC), a malignancy that develops in the upper section of the throat behind the nose, occurs in fewer than one person out of 100,000 worldwide each year. Locally advanced ...

Researchers in China have developed a powerful machine learning model that can help determine which patients with nasopharyngeal carcinoma (NPC) are likely to respond well to radiotherapy-a common ...

Anderson said her radiation oncologist at New York’s Memorial Sloan Kettering Cancer Center, Dr. Nancy Lee, told her after reviewing the scan that “if she wouldn’t have known I had NPC ...

Dublin, Jan. 05, 2023 (GLOBE NEWSWIRE) -- The "Global Nasopharyngeal Cancer Market Research and Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering. The global market ...